Article · 18 Sep 2021
Conference abstractPublished 29 Jul 2013
Post transplant bone disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
D espite improvement in some chronic kidney disease (CKD) metabolic derangements of bone and mineral metabolism after kidney transplantation, bone disease remains a significant problem. Kidney transplant recipients are at increased risk of bone mineral density (BMD) loss, fractures and osteonecrosis, all of which are associated with substantial morbidity .The pathogenesis of post transplant bone disease is multi-factorial including but not limited to interactions of the complex abnormalities in pre-transplant mineral homeostasis, renal osteodystrophy, the degree of persistently impaired kidney function, peri-transplant alternations in calciotropic and phosphotropic regulatory hormonal pathways, and the potential deleterious skeletal effects of immunosuppressive therapy. Management of post transplant bone disease is challenging given the limitations of the available diagnostic methods and the lack of proven benefit of available therapies to reduce fractures. Despite the evidence that both bisphosphonates and vitamin D receptor agonists (VDRA) attenuate the loss in BMD following successful kidney transplantation, these agents have not been clearly shown to reduce fractures. Moreover, there is no consensus on how to monitor the response to therapy and the optimal duration of therapy is unknown. Therefore, therapeutic decisions should be guided by consideration of the interplay of multiple factors including the severity of BMD loss, the presence of risk factors for osteoporotic fragility fractures, disordered mineral metabolism, underlying bone disorder, and the level of kidney function.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 30 Apr 2021
Prospective Study of Post Renal Transplant Mineral Bone Disorder: A Single Center Experience
Research article · 17 Sep 2020
Lymphorpoliferative diseases post-renal transplantation
Conference abstract · 20 May 2019
Treatment outcomes of direct-acting antiviral therapy among chronic kidney disease and post kidney transplant patients with hepatitis C virus infection: Single center experience
Conference abstract · 26 Jun 2017
Adoptive cellular immunotherapy for viral diseases post-transplant
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Hala M. Alshayeb”

